6-methoxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carbaldehyde, 95.0%, 250mg

1,3,5-Trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 10g

2-(Propan-2-ylidene)hydrazinecarboxamide, 98.0%, 500g

1-(Bromomethyl)-4-methoxybenzene (stabilised with K2CO3 2-5%), 95.0%, 5g

2-Hydrazinobenzothiazole>99.0%(T)25g

4-CHLOROPHENYL (S)-6-CHLORO-1-(4-METHOXYPHENYL)-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOLE-2-CARBOXYLATE, 95%, 5mg

3-(4-Isobutoxyphenyl)propanoic acid, 97%, 1g

Botella de boca ancha tipo 2104, transparente, 125 ml, 12 Unidad(es)

(1S,4S)-2,5-Diazabicyclo[2.2.1]heptane dihydrobromide, 97%, 100mg

Ethyl 2-vinyloxazole-4-carboxylate, 95% mix TBC as stabilizer, 250mg

(S)-2,2,2-Trifluoro-1-(3-methoxyphenyl)ethanamine hydrochloride, 97.0%, 250mg

Methyl 4-(((benzyloxy)carbonyl)amino)bicyclo[2.2.1]heptane-1-carboxylate, 98%, 500mg

4,5-Dichloro-1H-pyrrole-2-carbonitrile, 95+%, 250mg